Skip to content

The Affect of Low-Volume Bowel Preparation for Hospitalized Patients Colonoscopies

The Affect of Low-Volume Bowel Preparation for Hospitalized Patients Colonoscopies

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01978509
Enrollment
32
Registered
2013-11-07
Start date
2013-09-30
Completion date
2019-03-31
Last updated
2020-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colonoscopy

Keywords

Colonoscopy

Brief summary

The purpose of this study is to compare the efficacy of a low-volume bowel preparation versus a high-volume bowel preparation for bowel cleansing on hospitalized patients undergoing colonoscopies.

Interventions

DRUGLow volume prep (Prepopik)

Hospitalized patients will be randomized to receive either large volume bowel preparation (Golytely), moderate volume bowel prep (Moviprep) or low volume bowel preparation (Prepopik) in a split dose manner for bowel cleansing prior to colonoscopy.

DRUGModerate volume prep (Moviprep)

Hospitalized patients will be randomized to receive either large volume bowel preparation (Golytely), moderate volume bowel prep (Moviprep) or low volume bowel preparation (Prepopik) in a split dose manner for bowel cleansing prior to colonoscopy.

DRUGHigh volume prep (Golytely)

Hospitalized patients will be randomized to receive either large volume bowel preparation (Golytely), moderate volume bowel prep (Moviprep) or low volume bowel preparation (Prepopik) in a split dose manner for bowel cleansing prior to colonoscopy.

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Inpatient colonoscopy 2. Age 18 years and older 3. Able to give consent 4. Split dose colonoscopies for all patients

Exclusion criteria

1. Unable to give consent 2. Pregnant or lactating women 3. Renal impairment (GFR \<30) 4. Ileus 5. Ascites 6. Toxic megacolon 7. Gastrointestinal obstruction 8. Allergy to study drugs 9. Toxic colitis 10. Not able to split the dose of bowel preparations to be used 11. Contraindication to bowel preparation 12. Risk for aspiration 13. Risk of severe cardiac arrhythmias

Design outcomes

Primary

MeasureTime frameDescription
Bowel Cleansing24 hoursMeasured using the total Boston Bowel Prep Score (BBPS) obtained by adding scores from each segment for a range of minimum 0 = very poor and maximum 9 = excellent.

Secondary

MeasureTime frameDescription
Cancellation or Delay of Procedure Due to Poor Bowel Preparation24 hoursTo assess the rate of delayed and or cancellation of procedure due to inadequate bowel preparation

Other

MeasureTime frameDescription
Patient Tolerance24 hoursPercentage of participants self-reporting finishing the bowel preparation
Cecal Intubation24 hoursAssess the success of cecal intubation rate between three bowel preparations.

Countries

United States

Participant flow

Participants by arm

ArmCount
Low Volume Prep (Prepopik)
Low volume prep for colonoscopy (Prepopik) Low volume prep (Prepopik): Hospitalized patients will be randomized to receive either large volume bowel preparation (Golytely), moderate volume bowel prep (Moviprep) or low volume bowel preparation (Prepopik) in a split dose manner for bowel cleansing prior to colonoscopy.
10
Moderate Volume Prep (Moviprep)
Moderate volume prep for colonoscopy (Moviprep) Moderate volume prep (Moviprep): Hospitalized patients will be randomized to receive either large volume bowel preparation (Golytely), moderate volume bowel prep (Moviprep) or low volume bowel preparation (Prepopik) in a split dose manner for bowel cleansing prior to colonoscopy.
13
High Volume Prep (Golytely)
High volume prep for colonoscopy (Golytely) High volume prep (Golytely): Hospitalized patients will be randomized to receive either large volume bowel preparation (Golytely), moderate volume bowel prep (Moviprep) or low volume bowel preparation (Prepopik) in a split dose manner for bowel cleansing prior to colonoscopy.
9
Total32

Baseline characteristics

CharacteristicModerate Volume Prep (Moviprep)High Volume Prep (Golytely)TotalLow Volume Prep (Prepopik)
Age, Continuous56.13 years
STANDARD_DEVIATION 19.08
70.78 years
STANDARD_DEVIATION 12.33
63.66 years
STANDARD_DEVIATION 17.65
67 years
STANDARD_DEVIATION 17.54
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
United States
13 participants9 participants32 participants10 participants
Sex: Female, Male
Female
7 Participants3 Participants12 Participants2 Participants
Sex: Female, Male
Male
6 Participants6 Participants20 Participants8 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
0 / 100 / 130 / 9
other
Total, other adverse events
0 / 100 / 130 / 9
serious
Total, serious adverse events
0 / 100 / 130 / 9

Outcome results

Primary

Bowel Cleansing

Measured using the total Boston Bowel Prep Score (BBPS) obtained by adding scores from each segment for a range of minimum 0 = very poor and maximum 9 = excellent.

Time frame: 24 hours

ArmMeasureValue (MEAN)Dispersion
Low Volume Prep (Prepopik)Bowel Cleansing7.4 score on a scaleStandard Deviation 1.62
Moderate Volume Prep (Moviprep)Bowel Cleansing6.9 score on a scaleStandard Deviation 1.55
High Volume Prep (Golytely)Bowel Cleansing7.0 score on a scaleStandard Deviation 1.41
p-value: 0.7ANOVA
Secondary

Cancellation or Delay of Procedure Due to Poor Bowel Preparation

To assess the rate of delayed and or cancellation of procedure due to inadequate bowel preparation

Time frame: 24 hours

Population: Study was terminated due to lack of enrollment and data not collected.

Other Pre-specified

Cecal Intubation

Assess the success of cecal intubation rate between three bowel preparations.

Time frame: 24 hours

Population: Study was terminated due to lack of enrollment and data not collected.

Other Pre-specified

Patient Tolerance

Percentage of participants self-reporting finishing the bowel preparation

Time frame: 24 hours

ArmMeasureValue (NUMBER)
Low Volume Prep (Prepopik)Patient Tolerance100 percentage of participants
Moderate Volume Prep (Moviprep)Patient Tolerance75 percentage of participants
High Volume Prep (Golytely)Patient Tolerance77.8 percentage of participants

Source: ClinicalTrials.gov · Data processed: Feb 26, 2026